Table 2. Statistical analysis of key parameters.
| Group A | mean | SD | median | min | max | range | Significance |
|---|---|---|---|---|---|---|---|
| Age | 80.04 | 10.48 | 81 | 48 | 97 | 49 | p<0.00001 |
| No. of Comorbidities | 2.79 | 2.2 | 2 | 0 | 13 | 13 | p<0.00001 |
| Charlson Score | 5.11 | 1.93 | 5 | 0 | 9 | 9 | |
| Est. Relative Risk | 8 | 5.05 | 6.38 | 1 | 19.37 | 18.37 | p<0.00001 |
| Male | 11% | ||||||
| Female | 89% |
| Group B | mean | SD | median | min | max | range | Significance |
|---|---|---|---|---|---|---|---|
| Age | 60.44 | 19.79 | 65 | 14 | 96 | 82 | p<0.00001 |
| No. of Comorbidities | 1.39 | 1.16 | 1 | 0 | 4 | 4 | p<0.00001 |
| Charlson Score | 3.22 | 2.57 | 3 | 0 | 12 | 12 | |
| Est. Relative Risk | 4.84 | 4.65 | 3.04 | 1 | 19.37 | 18.37 | p<0.00001 |
| Male | 70% | ||||||
| Female | 30% |